Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
244
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+87.7M
-
Total reported value, excl. options
-
$1.87B
-
Value change
-
+$1.38B
-
Put/Call ratio
-
0.32
-
Number of buys
-
224
-
Number of sells
-
-19
-
Price
-
$15.79
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2024
266 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2024.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 835M outstanding shares and own 14.18% of the company stock.
Largest 10 shareholders include Robeco Institutional Asset Management B.V. (11.4M shares), MORGAN STANLEY (11.3M shares), Royal Bank of Canada (10M shares), BlackRock, Inc. (10M shares), RENAISSANCE TECHNOLOGIES LLC (9.42M shares), Aikya Investment Management Ltd (5.61M shares), DIMENSIONAL FUND ADVISORS LP (5.36M shares), VANGUARD GROUP INC (4.9M shares), STATE STREET CORP (4.66M shares), and BNP PARIBAS FINANCIAL MARKETS (2.9M shares).
This table shows the top 244 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.